Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Use Survey of Trelagliptin in Type 2 Diabetes Mellitus
jRCT1080223923Completed
- Sponsor
- Takeda
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of trelagliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Primary endpoint: Long-term safety of trelagliptin. Started Jun 2018; status: completed.
02
Drugs
trelagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080223923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223923.